CRI earnings: next report 2026-07-24, real EPS beat/miss history, analyst consensus Buy, P/E 15.10. Updated 2026-07-23.
Carter's (CRI) Research Hub
Carter's (CRI) trades on NYSE, US in the Consumer Cyclical (Specialty Retail) sector. As of 2026-09-11, shares last closed at 30.43 USD (-5.11%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 15.10, market cap 1.43B. This hub links to the full technical, earnings and options research available for CRI.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Consumer Cyclical (Specialty Retail) |
|---|---|
| Exchange | NYSE, US |
| Last close | 30.43 USD (-5.11%) |
| 52-week range | 30.105 USD – 44.28 USD |
| Trend regime | Range |
| 14-day RSI | 14.4 (Oversold) |
| Trailing P/E | 15.10 |
| Market cap | 1.43B |
| Dividend yield | 2.61% |
| Next earnings | 2026-07-24 |
Available research for CRI
Covered Call on CRI: how it works, illustrative setup around the real 30.43 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CRI: how it works, illustrative setup around the real 30.43 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CRI: how it works, illustrative setup around the real 30.43 USD price, max profit/loss, breakeven and when to use it. Educational.
CRI technical analysis: range, last 30.43 USD, RSI 14.4, 52w range 30.105 USD–44.28 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CRI in?
Carter's (CRI) is classified under Consumer Cyclical (Specialty Retail), listed on NYSE, US.
Is CRI in an uptrend or downtrend?
As of 2026-09-11, CRI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CRI's trailing P/E ratio?
CRI's trailing P/E is 15.10, with a market cap of 1.43B. See the earnings research page for full valuation detail.
When does CRI next report earnings?
CRI is next scheduled to report earnings on 2026-07-24, with a consensus EPS estimate of 0.06121 USD.